Lọc theo
New drug applications approved by US FDA as of 16 - 31 December 2020 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
People who eat yogurt appear to have a reduced risk of proximal colon cancer with a long latency period, a study has found. However, no significant benefit is seen for colorectal cancer (CRC) mortality.
Treatment with a chimeric antigen receptor (CAR) T-cell therapy yields high response in patients with relapsed/refractory (R/R) indolent non-Hodgkin lymphoma (iNHL) — driving tumour cells down to undetectable levels in close to 80 percent of these patients, according to the ZUMA-5 trial presented at ASH 2020.
Treatment with calcium supplementation with or without vitamin D appears to lower the risk of invasive cutaneous squamous cell carcinoma (SCC) but not basal cell carcinoma (BCC), a study has shown.
Treatment with darolutamide significantly improved overall survival (OS) in patients with nonmetastatic castration-resistant prostate cancer (nmCRPC), according to a prespecified final analysis of the ARAMIS* study presented at ESMO Asia 2020.
Omitting radiotherapy after breast-conserving surgery in older patients with hormone receptor (HR)-positive breast cancer who were also receiving appropriate systemic therapy did not impact overall survival (OS) at 10 years, even though the rate of local recurrence was higher than those who had radiotherapy, according to the PRIME* II study presented at SABCS 2020.
Alcohol consumption, even at low levels, contributes to an increased risk of developing gastric precancerous lesions, such as atrophic gastritis and intestinal metaplasia, a study has found.
The addition of low-dose capecitabine maintenance after completion of standard adjuvant chemotherapy led to significantly improved disease-free survival (DFS) among women with early-stage triple-negative breast cancer (TNBC), according to the SYSUCC-001* trial.
Patients with primary sclerosing cholangitis (PSC) who are treated with ursodeoxycholic acid (UDCA) may have a lower risk of liver transplantation, all-cause death, or biliary tract cancer, according to a study from Japan.
Inflammatory biomarkers are linked to obesity, dyslipidaemia, and insulin resistance among adolescent and young adult survivors of childhood acute lymphoblastic leukaemia (cALL), a recent study has found.
